Generation of an induced pluripotent stem cell line KUMCi001-A from CD34+bone marrow cells of a patient with acute lymphoblastic leukemia using human placenta-derived cell conditioned medium

被引:3
|
作者
Lee, Seung-Jin [1 ,2 ]
Kang, Ka-Won [3 ]
Kim, Ji-Hea [1 ,2 ]
Park, Young [3 ]
Kim, Byung-Soo [1 ,2 ,3 ]
机构
[1] Korea Univ, Inst Stem Cell Res, Coll Med, Seoul, South Korea
[2] Korea Univ, Grad Sch Med, Dept Biomed & Sci, Seoul, South Korea
[3] Korea Univ, Dept Internal Med, Anam Hosp, Med Ctr, Seoul, South Korea
关键词
D O I
10.1016/j.scr.2020.101913
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Many patients with acute lymphoblastic leukemia (ALL) show relapse post-chemotherapy. Therefore, it is important to develop a human induced pluripotent stem cell (hiPSC) line from ALL cells to verify the pathophysiology. However, the low efficiency of the established reprogramming protocol has hampered the development of ALL hiPSC lines. Our recently reported novel reprogramming method, using human placenta-derived cell conditioned medium (hPCCM), offers a relatively higher efficiency in humanized conditions. Here, we generated an hiPSC line from ALL-derived CD34+ bone marrow cells, using hPCCM for reprogramming. This hiPSC line might be a useful model for studies on ALL.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Supporting data on enhanced reprogramming of human CD34+ hematopoietic stem cells to induced pluripotent stem cells using human placenta-derived cell conditioned medium
    Lee, Seung-Jin
    Kim, Ji-Hea
    Kang, Ka-Won
    Park, Young
    Kim, Byung-Soo
    DATA IN BRIEF, 2020, 32
  • [2] Generation of normal induced pluripotent stem cell line KUMCi002-A from bone marrow CD34+cells of patient with multiple myeloma disease having 13q deletion and IGH translocation
    Lee, Seung-Jin
    Kim, Ji-Hea
    Kang, Ka-Won
    Lee, Byung-Hyun
    Kim, Byung-Soo
    STEM CELL RESEARCH, 2020, 49
  • [3] Efficient Commitment to Functional CD34+Progenitor Cells from Human Bone Marrow Mesenchymal Stem-Cell-Derived Induced Pluripotent Stem Cells
    Xu, Yulin
    Liu, Lizhen
    Zhang, Lifei
    Fu, Shan
    Hu, Yongxian
    Wang, Yingjia
    Fu, Huarui
    Wu, Kangni
    Xiao, Haowen
    Liu, Senquan
    Yu, Xiaohong
    Zheng, Weiyan
    Feng, Bo
    Huang, He
    PLOS ONE, 2012, 7 (04):
  • [4] Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type I
    Suga, Mika
    Kondo, Takayuki
    Imamura, Keiko
    Shibukawa, Ran
    Okanishi, Yasue
    Sagara, Yukako
    Tsukita, Kayoko
    Enami, Takako
    Furujo, Mahoko
    Saijo, Kaoru
    Nakamura, Yukio
    Osawa, Mitsujiro
    Saito, Megumu K.
    Yamanaka, Shinya
    Inoue, Haruhisa
    STEM CELL RESEARCH, 2019, 36
  • [5] Efficient Induction of CD34+Progenitor Cells From Human Bone Marrow Mesenchymal Stem Cell-Derived Induced Pluripotent Stem Cells with Defined Chemicals
    Xu, Yulin
    Liu, Lizhen
    Fu, Shan
    Zhang, Lifei
    Hu, Yongxian
    Liu, Senquan
    Wang, Yingjia
    Fu, Huarui
    Wu, Kangni
    Xiao, Haowen
    Yu, Xiaohong
    Zheng, Weiyan
    Huang, He
    BLOOD, 2011, 118 (21) : 1014 - 1015
  • [6] Generation of human induced pluripotent stem cell line (WMUi001-A) from a patient with aortic dissection
    Jin, Peifeng
    Wang, Sixian
    Jiang, Xu
    Shan, Xiaoqiong
    Jiang, Sheng
    Quan, Yingyi
    Zhang, Tianci
    Yang, Jiwen
    Zhang, Huang
    Ma, Jianshe
    Dong, Miaowu
    Fan, Junming
    Fan, Xiaofang
    Gong, Yongsheng
    Wang, Yongyu
    STEM CELL RESEARCH, 2020, 43
  • [7] Generation of a human induced pluripotent stem cell line PUMCi001-A from a patient with Krabbe disease
    Wang, Wei
    Lv, Ya-feng
    Zhang, Yan-jun
    Dong, Wen-ji
    Zhang, Ye
    STEM CELL RESEARCH, 2020, 48
  • [8] Using mast cells derived from human CD34+bone marrow stem cells to identify drugs that may produce pseudoallergic reactions
    Haskell, Keith
    Whritenour, Jessica
    Donahue, Christopher
    Blake, William
    Wolfram, Thaddeus
    He, Linyan
    Kawabata, Thomas
    Thiede, Mark
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [9] Human induced pluripotent stem cell line HMUi001-A derived from corneal stromal cells
    Bikkuzin, Timur
    Shi, Yan
    Sun, Baoqi
    Guo, Yiyuan
    Jin, Xin
    Han, Zhenbo
    Pavlov, Valentin
    Zhang, Hong
    STEM CELL RESEARCH, 2019, 37
  • [10] Establishment of an integration-free human induced pluripotent stem cell line (TJCi001-A) from normal bone marrow-derived mesenchymal stem cells
    Choi, Na Young
    Lee, YuRa
    Park, Yo Seph
    Ko, Kinarm
    Park, BoonSaeng
    Koh, Yong-Gon
    STEM CELL RESEARCH, 2021, 55